Welcome to our dedicated page for Bio Green Med Solution SEC filings (Ticker: BGMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bio Green Med Solution, Inc. filings document the company's fire safety protection and distribution business, its completed shift from the former Cyclacel Pharmaceuticals biopharmaceutical operations, and its public-company governance. Regulatory reports include 8-K disclosures for quarterly and annual results, Regulation FD releases, material agreements, warrant exchanges, and preferred-stock dividend declarations.
The filing record also covers the company's common stock and 6% Convertible Exchangeable Preferred Stock, proxy materials for annual stockholder matters, Nasdaq listing-compliance matters involving the preferred stock, and corporate history items such as the acquisition of Fitters Sdn. Bhd., the liquidation of the former U.K. subsidiary, and the sale of Plogosertib.
Bio Green Med Solution (BGMS) insider Yap Kim Choy reported a sale of common stock on 10/24/2025 under transaction code S (sale). The filing shows 19,595 shares disposed at a price of $1.902 per share.
After this transaction, the reporting person beneficially owns 384,870 shares, held directly. The filer is listed as a 10% owner.
Bio Green Med Solution (BGMS) reported insider activity on Form 4. Director Datuk Tan Chor How Christopher sold 92,352 shares of common stock on 10/21/2025 at a price of $3.005 per share (transaction code S). Following this sale, the reporting person beneficially owns 279,248 shares, held directly. This filing discloses a change in insider holdings and reflects a single reported transaction.
Bio Green Med Solution (BGMS) reported an insider transaction on Form 4. On 10/20/2025, 10% owner Datuk Tan Chor How Christopher sold 108,107 shares of common stock at $3.088 per share (Transaction Code: S). Following the sale, the reporting person beneficially owns 371,600 shares, held directly.
Bio Green Med Solution (BGMS) insider activity: Reporting person Kua Khai Loon, a director, filed a Form 4 disclosing open-market sales of BGMS common stock. On 10/15/2025, 7,479 shares were sold at $5.661, leaving 330,681 shares beneficially owned. On 10/16/2025, 88,204 shares were sold at $4.217, leaving 242,477 shares beneficially owned. Ownership is listed as Direct. The filing was made by one reporting person.
Bio Green Med Solution (BGMS) Form 4: A reporting person identified as a 10% owner reported a sale of common stock. On 10/16/2025, the holder sold 26,051 shares (transaction code S) at a price of $5.50 per share. Following this transaction, the filer beneficially owned 479,707 shares, held directly.
Bio Green Med Solution (BGMS): A reporting person filed a Form 4 showing an open‑market sale of common stock. On 10/14/2025, the filer sold 135,793 shares at $6 per share (Transaction Code S). Following the transaction, the filer reported 268,672 shares beneficially owned with direct ownership.
Bio Green Med Solution (BGMS) reported an insider transaction on a Form 4. A 10% owner sold 51,400 shares of common stock on 10/10/2025 at $5.258 per share (Transaction Code: S). Following the sale, the reporting person beneficially owned 505,758 shares, held directly. The filing was made by /s/ Datuk Tan Chor How Christopher on 10/14/2025.
Report overview: This Schedule 13G/A states that Kua Khai Loon beneficially owns 805,695 shares of Bio Green Med Solution, Inc. common stock, representing 16.35% of the class. The filing breaks ownership into 338,160 common shares and warrants totaling 467,535 (218,000 Series A warrants, 218,000 Series B warrants, and 31,535 Series C warrants) that are exercisable into common stock.
The filer certifies the shares were not acquired to change or influence control. The document lists the issuer's Kuala Lumpur address and the reporter's Malaysian residence, and it attaches warrant forms as exhibits.
Bio Green Med Solution (BGMS) filed a Form 4 reporting insider stock sales by Kua Khai Loon, a Director. On 09/12/2025, the insider sold 22,251 shares of common stock at $6.224 per share, leaving 363,160 shares beneficially owned. On 09/16/2025, the insider sold an additional 25,000 shares at $5.132 per share, with 338,160 shares beneficially owned afterward. Both positions are listed as Direct (D) ownership.
FITTERS Diversified Berhad, a director, reported a sale of $5.293-per-share common stock on 10/08/2025 for 142,000 shares, reducing its stake to 557,158 shares held directly. The Form 4 shows the transaction type as a sale and lists the reporting person’s address in Kuala Lumpur. The form was signed by Datuk Tan Chor How Christopher on 10/10/2025.